| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |